Clinical characteristics and prognostic factors of plasmablastic lymphoma patients
Clinical characteristics and prognostic factors of plasmablastic lymphoma patients
Blinatumomab improves survival of relapsed B-cell leukaemia
Decoding the risk of thromboembolic events in lymphoma patients
Activated JAK-STAT signaling co-operates with HOXA9 to drive leukaemia
SL401 in patients with rare neoplasm
RNA regulation of JAK-STAT pathways in CML
Pre-leukaemic clones that survive chemo linked to higher risk of AML recurrence
Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma
Ten years of letrozole improves survival and quality of life in early-diagnosed breast cancer.
Daratumumab slows progression in refractory multiple myeloma
Developments in haematological malignancies
Recent developments in targeted therapies